Bukwang- BK-JM-201 SHINE A Randomized, Double-Blind, Placebo-Controlled, Two-Part Study in Parkinson's Disease Patients With Dyskinesia to Assess the Efficacy and Safety/Tolerability of Fixed Dose Combinations of JM-010 and Its Individual Components

Project: Clinical Trial

Project Details

StatusActive
Effective start/end date7/30/21 → …